Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Cancergazing? CA125 and post-treatment surveillance in advanced ovarian cancer.

Jordens CF, Morrell B, Harnett P, Hobbs K, Mason C, Kerridge IH.

Soc Sci Med. 2010 Nov;71(9):1548-56. doi: 10.1016/j.socscimed.2010.07.033. Epub 2010 Aug 26.

PMID:
20832155
2.

New tumor markers: CA125 and beyond.

Bast RC Jr, Badgwell D, Lu Z, Marquez R, Rosen D, Liu J, Baggerly KA, Atkinson EN, Skates S, Zhang Z, Lokshin A, Menon U, Jacobs I, Lu K.

Int J Gynecol Cancer. 2005 Nov-Dec;15 Suppl 3:274-81. Review.

PMID:
16343244
3.
4.
5.

What surveillance plan should be advised for patients in remission after completion of first-line therapy for advanced ovarian cancer?

Rustin GJ.

Int J Gynecol Cancer. 2010 Oct;20(11 Suppl 2):S27-8. doi: 10.1111/IGC.0b013e3181f63a28. Review.

PMID:
20975357

Supplemental Content

Support Center